Test ointment for small basal cell skin cancers
Part of Cancer, Skin clinical trials.
This Phase 1/2 trial tests EscharEx (an investigational treatment) to see if it is safe and works on a single small basal cell skin cancer on the trunk or upper arms. You might qualify if your cancer fits specific size and location rules and you have not had radiation to that spot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- You have 1 confirmed basal cell skin cancer (superficial or nodular) on the trunk or upper arms (not hands), with clear edges
- The spot has been there 4 years or less, and is about 5–10 mm wide
- You have not had radiation therapy to that cancer area
- No infection or open, pus-like drainage where the spot is
- You’re able to read and sign consent and follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether 5-fluorouracil and calcipotriene (medicines used on the skin) can treat certain small, early skin cancers or pre-cancers without surgery. It’s for specific types and locations of lesions and aims to see how well the treatment works and how safe it is.
This study tests an experimental drug called FLD-103 injected into a specific type of skin cancer (nodular basal cell carcinoma) that hasn't been treated before. The goal is to see if it helps remove the cancer before final surgery.
This trial tests the safety and effectiveness of tirbanubulin gel to treat a type of skin cancer called superficial basal cell carcinoma (sBCC). It is for people who have not been treated for this cancer before and have a small spot (less than 1.5 cm) that is not on the face or scalp.
This trial tests combining a skin cream (imiquimod), a laser treatment, and an immunotherapy drug (cemiplimab) before surgery for high-risk basal cell carcinoma. The goal is to see if this combination shrinks tumors enough to make surgery less disfiguring or damaging to nearby functions.
This trial tests a new treatment that combines light (photodynamic therapy) and sound (sonodynamic therapy) to treat a common type of skin cancer called nodular basal cell carcinoma. The goal is to see if this combination works better than light alone for small tumors.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
Hear when a new Superficial Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.